WallStreetZenWallStreetZen

NASDAQ: CYCN
Cyclerion Therapeutics Inc Stock Ownership - Who owns Cyclerion Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cyclerion Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter M. HechtDirector2025-03-25181,818$2.75
$500.00kBuy
Michael J. 1. HigginsDirector2025-03-259,090$2.75
$25.00kBuy
Slate Path Capital LP10% Owner2024-11-21357,880$1.55
$555.07kSell

1 of 1

CYCN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCN insiders and whales buy or sell their stock.

CYCN Shareholders

What type of owners hold Cyclerion Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Terrance McGuire24.02%771,191$2.31MInsider
Amy W. Schulman19.74%633,625$1.90MInsider
Peter M. Hecht17.44%559,760$1.68MInsider
Andreas Busch7.93%254,704$764.11kInsider
Mark G. Currie7.84%251,648$754.94kInsider
Tyndall Capital Partners L P5.13%164,777$494.33kInstitution
Siren LLC3.62%116,155$348.47kInstitution
Regina Margaret Graul3.12%100,303$300.91kInsider
William Huyett2.11%67,590$202.77kInsider
Christopher I. Wright1.33%42,728$128.18kInsider

1 of 3

CYCN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCN11.60%88.40%Net Selling
QNRX1.95%7.08%Net Buying
CANF0.00%0.00%
APRE3.18%96.82%Net BuyingNet Buying
ACXP14.90%10.95%Net Buying
View Top Biotech Stocks

Cyclerion Therapeutics Stock Ownership FAQ

Who owns Cyclerion Therapeutics?

Cyclerion Therapeutics (NASDAQ: CYCN) is owned by 11.63% institutional shareholders, 88.65% Cyclerion Therapeutics insiders, and 0.00% retail investors. Terrance McGuire is the largest individual Cyclerion Therapeutics shareholder, owning 771,191.00 shares representing 24.02% of the company. Terrance McGuire's Cyclerion Therapeutics shares are currently valued at $2.31M.

If you're new to stock investing, here's how to buy Cyclerion Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.